CDH3 and cancer: On the other hand, regarding the positive percent score (PPS), 20/30 (66.7%) and 53/73 (70.7%) cases of endometrioid and serous subtypes, demonstrated P-cadherin expression in over 50% of cancer cells, respectively (Table 1b).